June 2, 2021

MorphImmune, Inc. Appoints Ronald Martell as President and CEO

— The former President and CEO of Nuvelution Pharma also served as the CEO of three public biopharmaceutical companies, including Sevion and NeurogesX, and has overseen […]
June 1, 2021

Targeted therapies developed to reduce lung fibrosis

June 1, 2021

Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs

June 1, 2021

Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models

June 1, 2021

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Contact

Connect With Us​

Do you have any questions or just want to connect? We would love to hear from you.